Prestige Brands’ OTC Revenue Climbs With Boost In Advertising
This article was originally published in The Tan Sheet
Prestige CEO Mannelly attributes the success of Clear Eyes, Chloraseptic, Compound W and Little Remedies to a $1 million increase in advertising and promotions. The OTC division’s net revenue soar 55.7% to $79.2 million.
You may also be interested in...
Prestige Brands gains from acquisitions
The impact of McNeil Consumer Healthcare's quality control lapses extends to Blacksmith Brands, which becomes a congressional inquiry target after recalling PediaCare products manufactured at one of the Johnson & Johnson subsidiary's plants
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.